AtriCure ATRC Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $108K— | —— | -$267K+95.7% | -$6.19M+8.3% | -$6.75M+56.7% | ||
| $2.89M-3.6% | $3M-2.0% | $3.06M0.0% | $3.06M+2.9% | $2.97M+1.1% | ||
| $11.27M+0.1% | $11.26M-9.4% | $12.42M+9.3% | $11.37M+18.1% | $9.63M-7.3% | ||
| $105K-11.8% | $119K-0.8% | $120K+0.8% | $119K-0.8% | $120K+0.8% | ||
| $5.02M+33.7% | $3.76M— | —— | $2.16M-19.7% | $2.69M-55.7% | ||
| $2.77M— | —— | $2.64M+220% | $824K+210% | -$750K— | ||
| $5.57M+537% | -$1.28M-454% | $360K— | —— | -$722K+87.5% | ||
| -$13.51M-465% | $3.71M-59.4% | $9.12M+35.6% | $6.73M+154% | -$12.56M-311% | ||
| $708K+9.3% | $648K+56.1% | $415K— | —— | $495K-65.9% | ||
| $2.38M+13.0% | $2.11M0.0% | $2.11M0.0% | $2.11M0.0% | $2.11M+11.9% | ||
| $5.16M— | —— | $205K— | —— | $3.89M+89.0% | ||
| -$4M-120% | $20.03M-25.0% | $26.72M+23.6% | $21.62M+296% | -$11.03M-289% | ||
| $3.85M+140% | $1.6M-38.5% | $2.61M-2.1% | $2.66M+22.1% | $2.18M-19.0% | ||
| -$3.85M-48.0% | -$2.6M+0.1% | -$2.61M+66.0% | -$7.66M-356% | -$1.68M— | ||
| $1.19M+272% | $321K+6.6% | $301K+3.1% | $292K+1.7% | $287K+2.1% | ||
| $11.44M+4,918% | $228K-36.1% | $357K-12.1% | $406K-96.0% | $10.17M+5,198% | ||
| $777K— | $0— | $0— | $0— | $0— | ||
| -$13.26M-732% | $2.1M— | —— | —— | -$10.33M— | ||
| -$160K-500% | $40K— | $0-100% | $537K+174% | $196K+140% | ||
| -$21.26M-209% | $19.56M-34.9% | $30.07M+67.9% | $17.91M+178% | -$22.84M— | ||
| $1.22M-8.7% | $1.34M-0.7% | $1.35M+1.3% | $1.33M+6.6% | $1.25M-47.0% | ||
| $91K— | —— | $748K-2.3% | $766K+560% | $116K+170% | ||
| $105K-11.8% | $119K-0.8% | $120K+0.8% | $119K-0.8% | $120K+0.8% | ||
| $2.38M+13.0% | $2.11M0.0% | $2.11M0.0% | $2.11M0.0% | $2.11M+11.9% | ||
| $2.89M-3.6% | $3M-2.0% | $3.06M0.0% | $3.06M+2.9% | $2.97M+1.1% | ||
| $5.16M— | —— | $205K— | —— | $3.89M+89.0% | ||
| $575K+63.4% | $352K-54.6% | $776K+56.1% | $497K-1.4% | $504K+80.6% | ||
| $777K— | $0— | $0— | $0— | $0— | ||
| $1.19M+272% | $321K+6.6% | $301K+3.1% | $292K+1.7% | $287K+2.1% | ||
| $0— | —— | —— | —— | $500K— | ||
| $158K— | —— | $392K-90.5% | $4.12M+2,972% | $134K— | ||
| $91K— | —— | $748K-2.3% | $766K+560% | $116K+170% | ||
| -$7.85M-143% | $18.43M-23.6% | $24.11M+27.2% | $18.96M+244% | -$13.21M-520% | ||
| -$7.85M-143% | $18.43M-23.6% | $24.11M+27.2% | $18.96M+244% | -$13.21M-520% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does AtriCure generate?
- AtriCure (ATRC) generated $64.4M in operating cash flow over the trailing twelve months.
- What is AtriCure's free cash flow?
- After $10.7M of capital expenditures, AtriCure's free cash flow was $53.6M over the trailing twelve months, up 249.2% year over year.
- Where does AtriCure's cash flow data come from?
- Every line is extracted from AtriCure's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
